Artwork
iconShare
 
Manage episode 295655410 series 2876046
Content provided by Grant Belgard and The Bioinformatics CRO. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Grant Belgard and The Bioinformatics CRO or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Mark Kotter, co-founder and CEO of Bit Bio, discusses the uses of reprogrammed human cells in research and drug development.

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.

https://www.bioinformaticscro.com/

  continue reading

69 episodes